glutamic acid has been researched along with Benign Neoplasms in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (13.08) | 18.7374 |
1990's | 3 (2.80) | 18.2507 |
2000's | 18 (16.82) | 29.6817 |
2010's | 43 (40.19) | 24.3611 |
2020's | 29 (27.10) | 2.80 |
Authors | Studies |
---|---|
Granchi, C | 1 |
Chen, X; Li, Y; Liu, J; Shen, A; Wu, B; Wu, X; Wu, Y; Yue, Y; Zhao, W | 1 |
Biggin, PC; Deme, JC; Kolokouris, D; Kuteyi, G; Lea, SM; Newstead, S; Parker, JL | 1 |
Arnold, N; Brandt, W; Frolov, A; Lam, YTH; Porzel, A; Rennert, R; Ricardo, MG; Stark, P; Westermann, B | 1 |
Chen, Z; Dai, SS; He, P; He, W; Liu, YW; Xiong, T; Xu, Z; Yang, T; Zhong, D; Zhou, M | 1 |
Le, A; Quinones, A; Zhang, C | 1 |
Itahana, K; Itahana, Y; Lee, Y; Ong, CC | 1 |
Abnous, K; Alibolandi, M; Hasannia, M; Nekooei, S; Ramezani, M; Taghdisi, SM | 1 |
Chen, K; He, J; Wang, J; Wang, X; Zhang, M | 1 |
Ackermann, T; Allega, MF; Bird, TG; Blancke, G; Bloom, A; Blyth, K; Deshmukh, R; Drake, TM; Huang, DT; Jans, M; Lewis, DY; May, S; Müller, M; Murphy, DJ; Nakasone, MA; Nixon, C; Oetjen, J; Sansom, OJ; Sumpton, D; Tan, EH; Tardito, S; Vande Voorde, J; Vereecke, L; Villar, VH | 1 |
Abousaida, B; Carter, R; Derry, P; Gonzalez, VV; Kim, JBK; Krishnan, S; Liopo, AV; Mackeyev, Y; Rauta, PR; Sanders, K; Shohayeb, MA; Singh, P; Tezcan, O; Vijay, GV; Zahra, Y; Zubarev, ER | 1 |
Chuang, YC; Kao, TW; Kuo, CC; Lee, HL; Shen, YA | 1 |
Abnous, K; Alibolandi, M; Hasannia, M; Lamei, K; Nekooei, N; Nekooei, S; Ramezani, M; Taghdisi, SM | 1 |
Li, Y; Lu, Y; Song, W; Xu, Y; Zhang, Y | 1 |
Oda, K; Wlodawer, A | 1 |
Crepaldi, T; Gallo, S; Vitacolonna, A | 1 |
Hu, J; Ju, X; Koda, S; Shao, S; Sun, G; Tang, RX; Yan, J; Zheng, KY | 1 |
Chang, YK; Chen, IC; Chen, MS; Hsu, CY; Huang, JW; Huang, WR; Liao, TL; Liu, HJ; Munir, M | 1 |
Alavizadeh, SH; Cabral, H; Jaafari, MR; Mohammadzadeh, V; Quader, S; Rahiman, N; Taghavizadeh Yazdi, ME; Zirak, MR | 1 |
Adler, L; Agron, S; Bahat, A; Ben-Zeev, E; Buchaklian, A; Dimmock, D; Erez, A; Geva, I; Helbling, D; Itkin, M; Levin-Zaidman, S; Malitsky, S; Porat, Z; Rabinovich, S; Silberman, A | 1 |
Mi, YY; Song, NH; Wang, ZJ; Yuan, W; Zhang, LF; Zhang, W; Zhu, LJ; Zuo, L | 1 |
Howlader, MMR; Schultz, J; Singh, G; Uddin, Z | 1 |
Cormerais, Y; Pouysségur, J; Vucetic, M | 1 |
Feng, B; Gao, D; Li, K; Lin, J; Liu, Q; Qiu, L; Wang, S; Ye, S | 1 |
Delfarah, A; Graham, NA; Joly, JH; Parrish, S; Phung, PS | 1 |
Ashley, J; Li, L; Mohammadniaei, M; Shen, J; Sun, Y; Wang, M; Wang, W; Wu, F; Zhang, M; Zhang, Q; Zheng, T | 1 |
Campos-Sandoval, JA; de Los Santos-Jiménez, J; Márquez, J; Matés, JM | 1 |
Cooney, KA; Helfand, BT; Hulick, PJ; Isaacs, WB; Na, R; Resurreccion, WK; Shi, Z; Wang, CH; Wei, J; Xu, J; Zheng, SL | 1 |
Luo, W; Peng, H; Wang, Y | 1 |
Gu, Y; Guo, S; Le, A; Qu, J | 1 |
Hoang, G; Le, A; Nguyen, K | 1 |
Abélanet, S; Audebert, S; Belhadj, I; Bertero, T; Brau, F; Chan, SY; Ewald, AJ; Grasset, EM; Haynes, M; Lacoux, C; Mari, B; Oldham, WM; Pisano, S; Torrino, S | 1 |
Cohen-Kaminsky, S; Dumas, SJ; Humbert, M | 1 |
Gan, B; Koppula, P; Li, W; Shi, J; Zhang, Y | 1 |
Eoh, H; Gao, SJ; Jung, JU; Lee, JJ; Li, T; Lu, C; Ramos da Silva, S; Zhu, Y | 1 |
Alvarez, SW; Biancur, D; Davidson, SM; Guzelhan, BS; Karagiannis, D; Karakousi, TR; LeBoeuf, SE; Morris, PJ; Muir, A; Papagiannakopoulos, T; Possemato, R; Sayin, VI; Singh, SX; Thomas, CJ; Ubriaco, J; Vander Heiden, MG; Wu, WL; Zavitsanou, AM | 1 |
Cao, S; Dong, N; Du, W; Tian, Y; Wang, Y; Wu, Y; Xu, Y | 1 |
Heianza, Y; Hu, FB; Huang, T; Ma, W; Manson, JE; Qi, L; Rexrode, KM; Sun, D; Wang, T; Zheng, Y | 1 |
Adriaensens, P; Giesen, P; Louis, E; Mesotten, L; Owokotomo, OE; Shkedy, Z; Thomeer, M; Vanhove, K | 1 |
Lee, HS; Mankoff, DA; Pantel, AR; Zhou, R | 1 |
Antonio, MJ; Asaka, R; Betenbaugh, MJ; Camelo, F; Chaichana, KL; Elgogary, A; Gabrielson, E; Hartung, T; Hoang, G; Jung, JG; Kirsch, BJ; Kleensang, A; Le, A; Li, T; Marie, SK; Nabi, K; Nguyen, K; Nguyen, S; Nguyen, T; Quinones, A; Reyes, J; Sazeides, C; Shen, YA; Tan, J; Udupa, S; Wang, TL; Zhao, L | 1 |
Ali, I; Haque, A; Saleem, K; Wani, WA | 1 |
Bell, EH; Chakravarti, A; Guo, D; Mischel, P | 1 |
Chen, X; Li, M; Liu, H; Lv, S; Song, W; Sun, H; Tang, Z | 1 |
Koochekpour, S; Willard, SS | 2 |
Balenko, MD; Nashed, MG; Singh, G | 1 |
Ikonomidou, C; Polberg, K; Rola, R; Stepulak, A | 1 |
D'Aquilla, K; DeBrosse, C; Hariharan, H; Nanga, RP; Reddy, R; Singh, A | 1 |
Kenney, JW; Moore, CE; Proud, CG; Wang, X | 1 |
Ahn, WS; Gameiro, PA; Keibler, MA; Stephanopoulos, G; Zhang, J; Zhang, Z | 1 |
Gou, J; Jin, J; Jin, X; Liu, J; Sui, B; Tang, X; Xu, H; Xu, J; Zhang, H; Zhang, Y | 1 |
Antonyak, MA; Cerione, RA; Katt, WP | 1 |
Bradfield, SM; Geller, T; Krischer, JP; Sandler, E; Tamura, RN | 1 |
Chen, T; Ding, S; Fu, S; Gu, Y; Lu, Y; Ruan, G; Sun, X; Teng, L; Wang, J; Wang, L; Wang, M | 1 |
Martín, VS; Padrón, JM; Silveira-Dorta, G | 1 |
Cao, W; Gao, G; Gu, Y; Li, S; Liu, M; Shan, L; Wu, C; Xu, L; Zhao, L | 1 |
Heese, K; Kutzner, A | 1 |
Adams, ND; DeBerardinis, RJ; Dranka, BP; Jiang, L; McCabe, MT; Metallo, CM; Parker, SJ; Pietrak, B; Schmidt, S; Schwartz, B; Shestov, AA; Swain, P; Terada, LS; Wang, QA; Yang, C | 1 |
Lisanti, MP; Martinez-Outschoorn, UE; Peiris-Pagés, M; Pestell, RG; Sotgia, F | 1 |
Budczies, J | 1 |
DIAMOND, LK; FARBER, S | 1 |
Falke, JJ; Landgraf, KE; Pilling, C | 1 |
Chen, X; Liu, S; Liu, Z; Wang, F | 1 |
Ames, JB; Gervay-Hague, J; Saludes, JP | 1 |
Brocke, KS; Geiger, KD; Ikonomidou, C; Luksch, H; Marzahn, J; Schackert, G; Staufner, C; Stepulak, A; Temme, A | 1 |
Hoang, BX; Hoang, C; Levine, SA; Nguyen, PM; Pham, PT; Shaw, DG; Tran, DM; Tran, HD; Tran, HQ | 1 |
Dang, CV | 1 |
Chuttani, K; Kakkar, D; Kaul, A; Mishra, AK; Singh, H; Tiwari, AK | 1 |
Azmi, A; Benzaria, A; Di Scala, C; Graoudi, S; Maresca, M; Taïeb, N; Varini, K | 1 |
Cho, SY; Foss, CA; Kim, HJ; Mease, RC; Pomper, MG | 1 |
Bauer, AJ; Cantley, AM; Dixon, SJ; Gleason, CE; Lamprecht, MR; Lemberg, KM; Morrison, B; Patel, DN; Skouta, R; Stockwell, BR; Yang, WS; Zaitsev, EM | 1 |
Prickett, TD; Samuels, Y | 1 |
Eckert, AW; Kappler, M; Schubert, J; Taubert, H; Vordermark, D | 1 |
Bera, RK; Dey, RS; Raj, CR | 1 |
Buckingham, SC; Robel, S | 1 |
WILTSHIRE, GH | 1 |
HILLMAN, G; HILLMAN-ELIES, A; METHFESSEL, F | 1 |
EAGLE, H; FLEISCHMAN, R; HORTON, CL; LEVY, M; OYAMA, VI | 1 |
BUSCH, H; NYHAN, WL | 2 |
IKEDA, T; IWATSURU, R; KAWATA, H; KAWATA, Y; MASUDA, T | 1 |
ROGOZNAIA, AV | 1 |
MAYER, C | 1 |
GREENBERG, DM; KIT, S | 1 |
Alonso, FJ; Campos-Sandoval, JA; González, ME; Manzanares, E; Márquez, J; Matés, JM; Pérez-Gómez, C; Ruiz-Sánchez, P; Segura, JA | 1 |
Bukowska, B | 1 |
Kalariti, N; Koutsilieris, M; Pissimissis, N | 1 |
Alonso, FJ; Márquez, J; Matés, JM; Segura, JA | 1 |
Binder, DK; Steinhäuser, C | 1 |
Delves, PJ; Iles, RK; Lund, T; Roitt, IM | 1 |
Graeme Shaw, D; Hoang, BX; Levine, SA; Pham, P | 1 |
Giovannini, C; Grande, S; Guidoni, L; Luciani, AM; Palma, A; Rosi, A; Sapora, O; Viti, V | 1 |
Chandra, H; Mishra, AK; Mishra, P; Shukla, G; Singh, S; Sinha, D; Tiwari, AK | 1 |
Gout, PW; Lo, M; Wang, YZ | 1 |
Jeong, EG; Kim, MS; Lee, SH; Yoo, NJ | 1 |
Coleman, PS; Lavietes, BB | 1 |
Goldberg, M; Hirschberger, J; Sauer, UG | 1 |
Bergljung, C; Bruna, J; Cerwinski, S; Chou, SJ; Fisher, GH; Gruneiro, A; Man, EH; Martin, T; Pappatheodorou, S; Torres, D | 1 |
Babylon, A; Breitkreutz, R; Dröge, W; Hack, V; Holm, E; Tokus, M | 1 |
Babylon, A; Böhles, H; Breitkreutz, R; Dröge, W; Edler, L; Hack, V; Hagmüller, E; Holm, E; Schuster, K; Tokus, M | 1 |
Pham, HT; Ruediger, R; Walter, G | 1 |
Ikonomidou, C; Rzeski, W; Turski, L | 1 |
Boschek, CB; Eigenbrodt, E; Grimm, H; Mazurek, S; Vaupel, P | 1 |
Phang, JM | 1 |
Betzler, M; Drings, P; Dröge, W; Ebert, W; Eck, HP; Schlag, P | 1 |
34 review(s) available for glutamic acid and Benign Neoplasms
Article | Year |
---|---|
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Topics: Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Dose-Response Relationship, Drug; Glucose; Humans; Lipid Metabolism; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
Metabolic reservoir cycles in cancer.
Topics: Glutamic Acid; Glutamine; Glycogen; Humans; Lactic Acid; Neoplasms; Triglycerides | 2022 |
The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
Topics: Amino Acid Transport System y+; Cell Line, Tumor; Cystine; Doxorubicin; Glutamic Acid; Humans; Neoplasms; Tumor Microenvironment | 2022 |
Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells.
Topics: Glucose; Glutamic Acid; Glutaminase; Glutamine; Humans; Neoplasms; Neoplastic Stem Cells | 2022 |
Poly(Glutamic Acid)-Engineered Nanoplatforms for Enhanced Cancer Phototherapy.
Topics: Glutamic Acid; Humans; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy | 2024 |
Overview of the Properties of Glutamic Peptidases That Are Present in Plant and Bacterial Pathogens and Play a Role in Celiac Disease and Cancer.
Topics: Asparagine; Bacteria; Celiac Disease; Glutamic Acid; Histidine; Humans; Neoplasms; Peptide Hydrolases | 2023 |
NMDA Receptor and Its Emerging Role in Cancer.
Topics: Glutamic Acid; Humans; Neoplasms; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synaptic Transmission | 2023 |
The role of glutamate receptors in the regulation of the tumor microenvironment.
Topics: Glutamic Acid; Humans; Neoplasms; Receptors, Glutamate; T-Lymphocytes; Tumor Microenvironment | 2023 |
Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Antigens; Dendritic Cells; Glutamic Acid; Humans; Nanoparticles; Neoplasms; Polyglutamic Acid; Tumor Microenvironment; Vaccination | 2023 |
Glutamate sensing in biofluids: recent advances and research challenges of electrochemical sensors.
Topics: Animals; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Glutamic Acid; Humans; Neoplasms; Neurodegenerative Diseases; Pain | 2020 |
Targeting amino acids transporters (SLCs) to starve cancer cells to death.
Topics: Amino Acid Transport System ASC; Amino Acid Transport Systems; Amino Acids; Antioxidants; Cell Line, Tumor; Cystine; Gene Expression Regulation; Glutamic Acid; Humans; Large Neutral Amino Acid-Transporter 1; Metabolome; Minor Histocompatibility Antigens; Molecular Targeted Therapy; Neoplasms | 2019 |
Glutaminases regulate glutathione and oxidative stress in cancer.
Topics: Animals; Antineoplastic Agents; Antioxidants; Energy Metabolism; Enzyme Inhibitors; Glutamic Acid; Glutaminase; Glutamine; Glutathione; Humans; Mitochondria; Neoplasms; Oxidative Stress; Signal Transduction; Tumor Microenvironment | 2020 |
Multifaceted role of branched-chain amino acid metabolism in cancer.
Topics: Amino Acids, Branched-Chain; Animals; Carcinogenesis; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Ketoglutaric Acids; Metabolic Networks and Pathways; Neoplasms; Nitrogen; Reactive Oxygen Species; Tumor Microenvironment | 2020 |
Targeting SREBP-1-driven lipid metabolism to treat cancer.
Topics: Animals; Cholesterol; Glutamic Acid; Glycolysis; Humans; Lipid Metabolism; Lipogenesis; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, LDL; Sterol Regulatory Element Binding Protein 1 | 2014 |
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Topics: Clinical Trials as Topic; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Male; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Signal Transduction | 2013 |
Glutamate, glutamate receptors, and downstream signaling pathways.
Topics: Amino Acid Sequence; Calcium; Calcium Signaling; Extracellular Signal-Regulated MAP Kinases; Glutamic Acid; Humans; Models, Biological; Molecular Sequence Data; Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Receptors, G-Protein-Coupled; Receptors, Glutamate; Sequence Alignment; Signal Transduction; Type C Phospholipases | 2013 |
Cancer-induced oxidative stress and pain.
Topics: Antineoplastic Agents; Antioxidants; Disease Progression; Female; Glutamic Acid; Humans; Male; Neoplasms; Nociceptive Pain; Oxidative Stress; Pain Management; Quality of Life | 2014 |
Glutamate and its receptors in cancer.
Topics: Animals; Glutamic Acid; Humans; Neoplasms; Receptors, Glutamate | 2014 |
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.
Topics: Autophagy; Calcium; Cytoprotection; Elongation Factor 2 Kinase; Gene Expression Regulation; Glutamic Acid; Humans; Muscle, Skeletal; Neoplasms; Phosphorylation; Signal Transduction; Synaptic Transmission; TOR Serine-Threonine Kinases | 2014 |
Cancer metabolism: a therapeutic perspective.
Topics: Acetyl Coenzyme A; Adaptation, Physiological; Amino Acids; Antineoplastic Agents; Antioxidants; Autophagy; Blood Glucose; Energy Metabolism; Epigenomics; Fatty Acids; Genetic Heterogeneity; Glutamic Acid; Glutamine; Humans; Ketone Bodies; Lactic Acid; Lipids; Mitochondria; Mitochondrial Ribosomes; Neoplasms; Nucleic Acids; Oxidative Stress; Pyruvic Acid; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Microenvironment | 2017 |
[Metabolome analysis of solid tumors].
Topics: 4-Aminobutyrate Transaminase; beta-Alanine; Biomarkers, Tumor; Breast; Breast Neoplasms; Colonic Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutaminase; Glutamine; Humans; Metabolome; Neoplasms; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Ovary | 2016 |
Dimethyl sulfoxide as an excitatory modulator and its possible role in cancer pain management.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Dimethyl Sulfoxide; Glutamic Acid; Humans; N-Methylaspartate; Neoplasms; Pain, Intractable; Quality of Life; Sodium Channels | 2010 |
GCPII imaging and cancer.
Topics: Animals; Antigens, Surface; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Molecular Imaging; Neoplasms; Prostate; Prostatic Neoplasms | 2012 |
Molecular pathways: dysregulated glutamatergic signaling pathways in cancer.
Topics: Animals; Glutamic Acid; Humans; Neoplasms; Receptors, Glutamate; Signal Transduction | 2012 |
Nanomaterial-based functional scaffolds for amperometric sensing of bioanalytes.
Topics: Animals; Biosensing Techniques; Blood Glucose; Cholesterol; Electrochemical Techniques; Equipment Design; Glutamic Acid; Humans; Immunoassay; Lactic Acid; Models, Molecular; Nanostructures; Neoplasms; Uric Acid | 2013 |
Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.
Topics: Blood-Brain Barrier; Epilepsy; Glutamic Acid; Homeostasis; Humans; Neoplasms; Neuroglia; Potassium | 2013 |
[Glutathione: its biosynthesis, induction agents and concentrations in selected diseases].
Topics: Animals; Cysteine; Cystine; Glutamic Acid; Glutathione; Glycine; Humans; Male; Neoplasms | 2004 |
The glutamatergic system outside the CNS and in cancer biology.
Topics: Amino Acid Transport System X-AG; Animals; Antineoplastic Agents; Central Nervous System; Glutamic Acid; Humans; Neoplasms; Peripheral Nervous System; Receptors, Glutamate | 2005 |
Pathways from glutamine to apoptosis.
Topics: Apoptosis; Cell Proliferation; Glutamic Acid; Glutamine; Humans; Neoplasms; Neurons; Oxidative Stress; Signal Transduction | 2006 |
Functional changes in astroglial cells in epilepsy.
Topics: Animals; Aquaporins; Astrocytes; Brain; Brain Injuries; Epilepsy; Glutamic Acid; Humans; Neoplasms; Potassium Channels; Tuberous Sclerosis; Vesicular Glutamate Transport Proteins | 2006 |
The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases.
Topics: Amino Acid Transport Systems; Animals; Antiporters; Cystine; Glutamic Acid; Humans; Neoplasms | 2008 |
Membrane cholesterol, tumorigenesis, and the biochemical phenotype of neoplasia.
Topics: Acetates; Animals; Asparagine; Aspartic Acid; Biological Transport, Active; Cell Division; Cell Membrane Permeability; Cholesterol; Citric Acid Cycle; Electron Spin Resonance Spectroscopy; Glucose; Glutamates; Glutamic Acid; Glutamine; Lipid Bilayers; Liver Neoplasms, Experimental; Membrane Lipids; Mitochondria; Mitochondria, Liver; Models, Biological; Neoplasms; Oxygen Consumption; Phenotype; Purines; Pyrimidines; Pyruvates; Pyruvic Acid; Surface Properties | 1981 |
Pyruvate kinase type M2: a crossroad in the tumor metabolome.
Topics: Animals; Cell Division; Fatty Acids; Glutamic Acid; Humans; Hydrogen; Neoplasm Proteins; Neoplasms; Pyruvate Kinase | 2002 |
The regulatory functions of proline and pyrroline-5-carboxylic acid.
Topics: Amino Acids; Animals; Biological Transport; Cell Communication; Cell Cycle; Charcoal; Glutamates; Glutamic Acid; Humans; Mitosis; NADP; Neoplasms; Ornithine; Oxidation-Reduction; Phosphoribosyl Pyrophosphate; Proline; Protein Biosynthesis; Purine Nucleotides; Pyrroles; Structure-Activity Relationship | 1985 |
2 trial(s) available for glutamic acid and Benign Neoplasms
Article | Year |
---|---|
Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Double-Blind Method; Female; Glutamic Acid; Humans; Male; Neoplasms; Neurotoxicity Syndromes; Vincristine | 2015 |
Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases.
Topics: Adult; Aged; Animals; Cachexia; Carnitine; Double-Blind Method; Extremities; Female; Glutamic Acid; Glutathione; Humans; Male; Mice; Middle Aged; Mitochondria; Muscle, Skeletal; Neoplasms | 2000 |
71 other study(ies) available for glutamic acid and Benign Neoplasms
Article | Year |
---|---|
Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer.
Topics: Carrier Proteins; DNA Methylation; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Neoplasms; Phosphorylation; Protein Interaction Maps; Survival Analysis; WD40 Repeats | 2021 |
Molecular basis for redox control by the human cystine/glutamate antiporter system xc
Topics: Amino Acid Transport System y+; Antiporters; Biochemistry; Cryoelectron Microscopy; Cysteine; Cystine; Fusion Regulatory Protein 1, Heavy Chain; Glutamic Acid; Glutathione; HEK293 Cells; Humans; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species; Up-Regulation | 2021 |
Rare Glutamic Acid Methyl Ester Peptaibols from
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Botrytis; Esters; Glutamic Acid; Humans; Hypocreales; Neoplasms; Peptaibols; Phytophthora infestans; Tumor Cells, Cultured | 2021 |
Glutamate blunts cell-killing effects of neutrophils in tumor microenvironment.
Topics: Apoptosis; Glutamic Acid; Humans; Neoplasms; Neutrophils; Tumor Microenvironment | 2022 |
Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
Topics: Amino Acid Transport System y+; AMP-Activated Protein Kinases; Cell Line, Tumor; Cystine; Glucose; Glutamic Acid; Neoplasms; Oxidation-Reduction | 2022 |
Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer.
Topics: Animals; Carboxylic Acids; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Epithelial Cell Adhesion Molecule; Glutamic Acid; Gold; Maleimides; Mice; Nanotubes; Neoplasms; Peptides; Polyethylene Glycols; Sulfhydryl Compounds; Tomography, X-Ray Computed | 2022 |
Hepatic glutamine synthetase controls N
Topics: Ammonia; Animals; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Homeostasis; Humans; Liver; Mammals; Mice; Neoplasms | 2023 |
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization.
Topics: Acidosis; Animals; Cell Line, Tumor; Glutamic Acid; Gold; Hypoxia; Lysine; Mice; Nanotubes; Neoplasms; Tumor Microenvironment | 2022 |
Targeted poly(L-glutamic acid)-based hybrid peptosomes co-loaded with doxorubicin and USPIONs as a theranostic platform for metastatic breast cancer.
Topics: Animals; Cell Line, Tumor; Cricetinae; Cricetulus; Doxorubicin; Drug Carriers; Drug Delivery Systems; Glutamic Acid; Magnetic Iron Oxide Nanoparticles; Mice; Nanoparticles; Neoplasms; Polyesters; Polymers; Precision Medicine; Tissue Distribution | 2023 |
Oncolytic Avian Reovirus σA-Modulated Upregulation of the HIF-1α/C-myc/glut1 Pathway to Produce More Energy in Different Cancer Cell Lines Benefiting Virus Replication.
Topics: Glutamic Acid; HeLa Cells; Humans; Lactates; Neoplasms; Orthoreovirus, Avian; Signal Transduction; Up-Regulation; Virus Replication | 2023 |
The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis.
Topics: Carbohydrates; Carcinogenesis; Citrullinemia; Cytosol; Gene Expression Regulation, Neoplastic; Germ-Line Mutation; Glutamates; Glutamic Acid; Glycolysis; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Molecular Targeted Therapy; Neoplasms; Oxidative Phosphorylation | 2020 |
MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer.
Topics: Genetic Predisposition to Disease; Glutamic Acid; Humans; Lysine; Matrix Metalloproteinase 8; Neoplasms; Polymorphism, Single Nucleotide; Threonine | 2019 |
A New γ-Glutamyltranspeptidase-Based Intracellular Self-Assembly of Fluorine-18 Labeled Probe for Enhancing PET Imaging in Tumors.
Topics: Animals; Cell Line; Fluorine Radioisotopes; gamma-Glutamyltransferase; Glutamic Acid; Mice, Nude; Neoplasms; Positron-Emission Tomography | 2020 |
A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
Topics: Amino Acid Transport System y+; Antineoplastic Combined Chemotherapy Protocols; Antiporters; Cell Death; Cell Line, Tumor; Cell Survival; Cysteine; Cystine; Dimerization; Glucose; Glucose Transporter Type 1; Glutamic Acid; Glutathione; Humans; Metabolome; NADP; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species; Synthetic Drugs | 2020 |
Biodegradable Poly(γ-glutamic acid)@glucose oxidase@carbon dot nanoparticles for simultaneous multimodal imaging and synergetic cancer therapy.
Topics: Carbon; Cell Line, Tumor; Glucose Oxidase; Glutamic Acid; Hydrogen Peroxide; Multimodal Imaging; Nanoparticles; Neoplasms; Photochemotherapy; Polyglutamic Acid | 2020 |
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
Topics: Adult; Aged; Amino Acid Substitution; Biological Specimen Banks; Case-Control Studies; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Germ-Line Mutation; Glutamic Acid; Glycine; Homeodomain Proteins; Humans; Male; Middle Aged; Mutation, Missense; Neoplasms; Risk Factors; United Kingdom | 2020 |
Bridging the Metabolic Parallels Between Neurological Diseases and Cancer.
Topics: Dipeptides; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Neoplasms; Organophosphorus Compounds | 2021 |
Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy.
Topics: Cardiovascular Diseases; Glutamic Acid; Glutaminase; Glutamine; Humans; Neoplasms | 2021 |
Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis.
Topics: Animals; Cells, Cultured; Energy Metabolism; Female; Glutamic Acid; HeLa Cells; Humans; Mechanotransduction, Cellular; Mice; Mice, Inbred BALB C; Microtubules; Neoplasm Metastasis; Neoplasms; Protein Processing, Post-Translational; Tubulin; Tumor Microenvironment | 2021 |
[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?]
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Energy Metabolism; Glutamic Acid; Humans; Hypertension, Pulmonary; Metabolic Diseases; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasms; Signal Transduction; Tumor Escape; Vascular Remodeling; Vasodilator Agents | 2016 |
The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Topics: Absorption, Physiological; Amino Acid Transport System y+; Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; CRISPR-Cas Systems; Embryo, Mammalian; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glucose; Glutamic Acid; HEK293 Cells; Humans; Ketoglutaric Acids; Mice; Neoplasm Proteins; Neoplasms; Recombinant Proteins | 2017 |
A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
Topics: Asparagine; Aspartate Aminotransferases; Aspartic Acid; Cell Proliferation; Glutamate Dehydrogenase; Glutamic Acid; Glutaminase; Glutamine; Herpesvirus 8, Human; Humans; Metabolic Networks and Pathways; Neoplasms; Nitrogen; Nucleotides | 2017 |
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.
Topics: Animals; Antioxidants; Carbon; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glutamic Acid; Glutathione; Homeostasis; Humans; Mice; Neoplasms; NF-E2-Related Factor 2 | 2017 |
Systematic analyses of glutamine and glutamate metabolisms across different cancer types.
Topics: Gene Expression Regulation, Neoplastic; Glutamic Acid; Glutamine; Humans; Neoplasms | 2017 |
Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Life Style; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; United States | 2018 |
The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Glutamic Acid; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
A PET Glutamate Analogue to Measure Cancer Cell Redox State and Oxidative Stress: Promise and Paradox.
Topics: Glutamic Acid; Humans; Neoplasms; Oxidation-Reduction; Oxidative Stress; Positron-Emission Tomography | 2019 |
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.
Topics: Glutamic Acid; Humans; Neoplasms | 2019 |
Glutamic acid and its derivatives: candidates for rational design of anticancer drugs.
Topics: Antineoplastic Agents; Drug Carriers; Drug Design; Glutamic Acid; Humans; Neoplasms; Thalidomide | 2013 |
Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Endocytosis; Glutamic Acid; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Magnetic Resonance Spectroscopy; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Peptides; Polyethylene Glycols; Solutions; Surface-Active Agents; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Glutaminase catalyzes reaction of glutamate to GABA.
Topics: Brain; gamma-Aminobutyric Acid; Glucose; Glutamate Decarboxylase; Glutamic Acid; Glutaminase; Glycolysis; Humans; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Biological; Neoplasms | 2014 |
13C isotope-assisted methods for quantifying glutamine metabolism in cancer cells.
Topics: Biochemistry; Carbon Isotopes; Cell Hypoxia; Cells, Cultured; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutamine; Humans; Lipids; Neoplasms | 2014 |
Self-assembled micelles composed of doxorubicin conjugated Y-shaped PEG-poly(glutamic acid)2 copolymers via hydrazone linkers.
Topics: Cell Survival; Doxorubicin; Drug Delivery Systems; Glutamic Acid; HeLa Cells; Humans; Hydrazones; Hydrogen-Ion Concentration; Micelles; Neoplasms; Peptides; Polymers | 2014 |
Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention.
Topics: Allosteric Site; Ammonia; Antineoplastic Agents; Catalysis; Catalytic Domain; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Glutamic Acid; Glutamine; GTP-Binding Proteins; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Kidney; Neoplasm Metastasis; Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases | 2015 |
Perioperative dynamics and significance of amino acid profiles in patients with cancer.
Topics: Alanine; Amino Acids; Apoptosis; Biomarkers, Tumor; Case-Control Studies; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Glutamic Acid; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms; Perioperative Care | 2015 |
Synthesis and antiproliferative activity of glutamic acid-based dipeptides.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Glutamic Acid; HeLa Cells; Humans; Neoplasms; Structure-Activity Relationship | 2015 |
Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Arginine; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Folic Acid; Glutamic Acid; HEK293 Cells; Humans; Lethal Dose 50; Male; Mice; Mice, Nude; Molecular Weight; Neoplasms; Paclitaxel; Prodrugs; Solubility; Toxicity Tests, Acute; Xenograft Model Antitumor Assays | 2015 |
Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer.
Topics: Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Computational Biology; Databases, Genetic; DNA Mutational Analysis; Genetic Predisposition to Disease; Glutamic Acid; Humans; Mutation; Neoplasms; Phenotype; Protein Interaction Maps; Signal Transduction | 2016 |
Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
Topics: Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Citric Acid; Contact Inhibition; Cytosol; Extracellular Matrix; Glucose; Glutamic Acid; Glutamine; Homeostasis; Humans; Isocitrate Dehydrogenase; Isocitrates; Mitochondria; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Spheroids, Cellular | 2016 |
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.
Topics: Acute Disease; Child; Folic Acid Antagonists; Glutamic Acid; Humans; Leukemia; Neoplasms | 1948 |
Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.
Topics: 3T3 Cells; Animals; Cattle; Cell Membrane; Cell Survival; Glutamic Acid; Humans; Kinetics; Lysine; Mice; Microscopy, Fluorescence; Mutation; Neoplasms; Oncogenes; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2008 |
Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Topics: Animals; Azides; Dimerization; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Integrin alphaVbeta3; Iodine Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oligopeptides; Polyethylene Glycols; Positron-Emission Tomography; Radiochemistry; Tissue Distribution | 2009 |
Synthesis and structural characterization of sialic acid-glutamic acid hybrid foldamers as conformational surrogates of alpha-2,8-linked polysialic acid.
Topics: Amino Acid Sequence; Circular Dichroism; Glutamic Acid; Humans; Molecular Conformation; Molecular Mimicry; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Peptides; Protein Structure, Secondary; Sialic Acids | 2009 |
Glutamate receptors in pediatric tumors of the central nervous system.
Topics: Brain; Central Nervous System; Child; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Neoplasms; Neurotransmitter Agents; Protein Subunits; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?
Topics: Amino Acids; Carbon; Citric Acid Cycle; Energy Metabolism; Glucose; Glutamic Acid; Glutamine; Glycolysis; Humans; Neoplasms; Nitrogen; Proto-Oncogene Proteins c-myc | 2010 |
Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Topics: Animal Structures; Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cysteine; Drug Stability; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Molecular Structure; Neoplasms; Pentetic Acid; Rabbits; Radiopharmaceuticals; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2010 |
Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: effect of the cell confluence.
Topics: Amino Acid Transport System X-AG; Amino Acid Transport Systems; Astrocytes; Astrocytoma; Biological Transport; Blotting, Western; Cell Fractionation; Cell Line, Tumor; Glutamic Acid; Humans; Microscopy, Fluorescence; Neoplasms | 2012 |
Ferroptosis: an iron-dependent form of nonapoptotic cell death.
Topics: Animals; Cell Death; Cyclohexylamines; Fibroblasts; Glutamic Acid; Hippocampus; Humans; In Vitro Techniques; Iron; Lipid Metabolism; Neoplasms; Phenylenediamines; Piperazines; Rats; Reactive Oxygen Species | 2012 |
The real face of HIF1α in the tumor process.
Topics: Ammonia; Glucose Transporter Type 1; Glutamic Acid; Glutamine; Humans; Hydrogen-Ion Concentration; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Quaternary Ammonium Compounds | 2012 |
The optical form of glutamic acid in tumours.
Topics: Glutamates; Glutamic Acid; Neoplasms; Proteins | 1953 |
Metabolism and the occurrence of d(--)glutamic acid in tumour proteins.
Topics: Glutamic Acid; Humans; Neoplasm Proteins; Neoplasms; Proteins | 1954 |
The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid.
Topics: Animals; Glutamates; Glutamic Acid; Glutamine; Humans; Neoplasms; Tissue Culture Techniques | 1956 |
Metabolic patterns for L-glutamate-U-C14 in slices of tumors and other tissues.
Topics: Glutamates; Glutamic Acid; Neoplasms | 1957 |
[Studies on the biochemical changes during experimental carcinogenesis. I. The effects of pyridoxine and glutamic acid].
Topics: Carcinogenesis; Glutamates; Glutamic Acid; Neoplasms; Pyridoxine; Vitamin B 6 | 1957 |
Metabolic patterns for L-glutamate-U-C14 in tissues of tumor-bearing rats.
Topics: Animals; Glutamates; Glutamic Acid; Neoplasms; Rats | 1958 |
[CONDITION OF THE AMMONIA-GLUTAMINE-GLUTAMIC ACID SYSTEM IN THE RAT BRAIN DURING THE DEVELOPMENT OF M-1 SARCOMA].
Topics: Ammonia; Animals; Brain; Brain Chemistry; Glutamates; Glutamic Acid; Glutamine; Metabolism; Neoplasms; Rats; Research; Sarcoma; Sarcoma, Experimental | 1964 |
[Relation between cancer and D-glutamic acid].
Topics: Glutamic Acid; Neoplasms | 1951 |
Tracer studies on the metabolism of the Gardner lymphosarcoma. IV. The conversion of lactate-2-C14 to alanine, glutamate, and aspartate by tumor and spleen cells.
Topics: Alanine; Aspartic Acid; Glutamates; Glutamic Acid; Lactic Acid; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Spleen | 1951 |
[Glutamic acid and neoplasms].
Topics: Glutamates; Glutamic Acid; Humans; Neoplasms | 1951 |
Co-expression of glutaminase K and L isoenzymes in human tumour cells.
Topics: Biomarkers; Blotting, Western; Brain; Cell Proliferation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamic Acid; Glutaminase; Humans; Isoenzymes; Kidney; Kinetics; Leukemia; Liver; Neoplasms; Phosphates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2005 |
Designing a new generation of anti-hCG vaccines for cancer therapy.
Topics: Animals; Antigens, Neoplasm; Chorionic Gonadotropin, beta Subunit, Human; Drug Design; Female; Glutamic Acid; Humans; Mice; Models, Immunological; Mutation; Neoplasms; Pregnancy; Protein Structure, Secondary; Vaccines, Synthetic | 2007 |
Neuro-bioenergetic concepts in cancer prevention and treatment.
Topics: Acetylcholine; Antineoplastic Agents; Carcinogens; Fatty Acids; Glutamic Acid; Humans; Magnesium; Mutation; N-Methylaspartate; Neoplasms; Neurotransmitter Agents; Nitric Oxide; Purinergic P1 Receptor Antagonists; Sodium Channels; Somatomedins | 2007 |
Metabolism of glutathione in tumour cells as evidenced by 1H MRS.
Topics: Buthionine Sulfoximine; Cell Line, Tumor; Cysteine; Glutamic Acid; Glutathione; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Protons; Time Factors | 2007 |
Synthesis, characterization and biological activity of Schiff base analogues of indole-3-carboxaldehyde.
Topics: Animals; Bacteria; Fungi; Glutamic Acid; Half-Life; Histidine; Humans; Indoles; Mice; Neoplasms; Rabbits; Schiff Bases; Technetium; Tissue Distribution | 2008 |
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; DNA Mutational Analysis; Female; Glutamic Acid; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Lysine; Male; Middle Aged; Mutation; Neoplasms; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2008 |
Glutamine and glutamate in ascitic fluid of dogs.
Topics: Amino Acids; Animals; Ascites; Ascitic Fluid; Dog Diseases; Dogs; Glutamates; Glutamic Acid; Glutamine; Heart Failure; Hypoproteinemia; Liver Cirrhosis; Neoplasms; Peritonitis | 1993 |
Presence of D-aspartate and D-glutamate in tumor proteins.
Topics: Aspartic Acid; Glutamic Acid; Humans; Neoplasm Proteins; Neoplasms; Stereoisomerism | 1995 |
Linkage between postabsorptive amino acid release and glutamate uptake in skeletal muscle tissue of healthy young subjects, cancer patients, and the elderly.
Topics: Adult; Aged; Alanine; Amino Acids; Glutamic Acid; Humans; Intestinal Absorption; Linear Models; Male; Middle Aged; Muscle, Skeletal; Neoplasms; Postprandial Period; Reference Values | 1997 |
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.
Topics: Amino Acid Sequence; Arginine; Aspartic Acid; Breast Neoplasms; Female; Glutamic Acid; Glycine; Humans; Lung Neoplasms; Melanoma; Molecular Sequence Data; Neoplasms; Peptide Fragments; Phosphoprotein Phosphatases; Point Mutation; Protein Binding; Protein Phosphatase 2; Protein Structure, Secondary; Tryptophan | 2001 |
Glutamate antagonists limit tumor growth.
Topics: Anti-Anxiety Agents; Antineoplastic Agents; Benzodiazepines; Cell Division; Cell Movement; Cisplatin; Cyclophosphamide; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamic Acid; Growth Inhibitors; HT29 Cells; Humans; Immunohistochemistry; Neoplasms; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Thiotepa; Tumor Cells, Cultured; Vinblastine | 2001 |
Plasma glutamate concentration and lymphocyte activity.
Topics: Adult; Animals; Female; Glutamates; Glutamic Acid; Humans; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Neoplasms | 1988 |